Researcher develops vaccine for lethal E. coli bugApril 15th, 2009 - 4:12 pm ICT by IANS
Washington, April 15 (IANS) A researcher has developed a working vaccine for a strain of E. coli that kills up to three million children worldwide every year.
Enterotoxigenic E. Coli (ETEC), which accounts for 60 to 70 percent of all E. coli diarrhoeal disease, also causes health problems for US troops overseas and is responsible for what is commonly called traveller’s diarrhoea.
A. Mahdi Saeed, professor of epidemiology and infectious disease in Michigan State University (MSU), has applied for a patent for his discovery and has made contact with pharmaceutical companies for commercial production.
“This strain of E. coli is an international health challenge that has a huge impact on humanity,” said Saeed, who has devoted four years to develop a working vaccine at MSU’s National Food Safety and Toxicology Center. “By creating a vaccine, we can save untold lives. The implications are massive.”
ETEC affects millions of adults and children across the globe, mainly in the southern hemisphere countries throughout Africa and South America. It also poses a risk to US troops serving in southern Asia and the Middle East.
Saeed’s breakthrough was discovering a way to overcome the molecular size of one of the illness-inducing toxins produced by the E. coli bug.
Since the toxin was so small, it did not prompt the body’s defense system to develop immunity, allowing the same individual to repeatedly get sick, often with more severe health implications.
Saeed created a biological carrier to attach to the toxin that once introduced into the body induces a strong immune response. This was done by mapping the toxin’s biology and structure during the design of the vaccine. Saeed’s work was funded in part by a $510,000 grant from the National Institutes of Health.
After creating the carrier in a lab at MSU, Saeed and his team tested it on mice and found the biological activity of the toxin was enhanced by more than 40 percent, leading to its recognition by the body’s immune system.
After immunizing a group of 10 rabbits, the vaccine led to the production of the highest neutralizing antibody ever reported for this type of the toxin, said a MSU release.
Saeed hopes that human clinical trials could begin late in the year.
- Novel vaccine to combat deadliest strain of E. coli developed - Apr 15, 2009
- Structure of bacteria responsible for traveler's diarrhea identified - Jun 09, 2009
- Universal flu vaccine shows promise - Jun 08, 2011
- Anthrax shot protects simians from lethal infection - Jan 13, 2012
- Scientists discover E coli's Achilles heel - Jul 16, 2012
- How E. coli triggers urinary infections - Jan 19, 2012
- Copper effective against new E. coli strains - Jun 03, 2011
- Faster-growing E. coli strain may benefit human health - Nov 12, 2010
- New strain of killer E. coli decoded - Jul 27, 2012
- Here's how E. coli bacterium causes illness - Mar 15, 2011
- Vaccine for urinary tract infections comes closer to reality - Sep 18, 2009
- 'No mutation of swine flu virus' - Apr 11, 2012
- National Beef recalls beef over e-coli concerns - Aug 15, 2011
- Qatar bans vegetable imports fearing E. coli infection - Jun 05, 2011
- Vaccine made with synthetic gene shows promise against pneumonia - Feb 22, 2011
Tags: biological activity, diarrhoea, e coli, etec, health challenge, health implications, health problems, immune response, infectious disease, international health, mahdi, michigan state university, msu, national food safety, national institutes of health, pharmaceutical companies, southern asia, southern hemisphere countries, toxicology center, toxin